» Articles » PMID: 40008392

Late-Onset Progressive Osseous Heteroplasia: 2 Unrelated Cases and Use of Positron Emission Tomography for Diagnosis

Overview
Journal JCEM Case Rep
Specialty Endocrinology
Date 2025 Feb 26
PMID 40008392
Authors
Affiliations
Soon will be listed here.
Abstract

Progressive osseous heteroplasia (POH) is a rare autosomal-dominant hereditary bone disorder caused by inactivating pathogenic variants in . POH is characterized by progressive cutaneous ossification and heterotopic ossification in skeletal muscles and subdermal connective tissues. Understanding of the natural history and phenotypic heterogeneity of the illness is incomplete. We report 2 affected male subjects with a milder than usual clinical course, highlight their clinical presentations and molecular correlates, and propose sodium F-fluorine positron emission tomography (PET) scanning as a sensitive technique for POH diagnosis and management.

References
1.
Juppner H, Bastepe M . Different mutations within or upstream of the GNAS locus cause distinct forms of pseudohypoparathyroidism. J Pediatr Endocrinol Metab. 2006; 19 Suppl 2:641-6. DOI: 10.1515/jpem.2006.19.s2.641. View

2.
Han S, Lee Y, Shin C, Yang S, Lim B, Cho T . Clinical and Molecular Characteristics of GNAS Inactivation Disorders Observed in 18 Korean Patients. Exp Clin Endocrinol Diabetes. 2019; 129(2):118-125. DOI: 10.1055/a-1001-3575. View

3.
Suntharesan J, Lyulcheva-Bennett E, Hart R, Pizer B, Hayden J, Ramakrishnan R . Medulloblastoma in a child with osteoma cutis - a rare association due to loss of expression. J Pediatr Endocrinol Metab. 2024; 37(5):467-471. DOI: 10.1515/jpem-2023-0533. View

4.
Pereda A, Martos-Tello J, Garin I, Errea-Dorronsoro J, Perez de Nanclares G . Progressive osseous heteroplasia caused by a mosaic GNAS mutation. Clin Endocrinol (Oxf). 2018; 88(6):993-995. DOI: 10.1111/cen.13584. View

5.
Pignolo R, Ramaswamy G, Fong J, Shore E, Kaplan F . Progressive osseous heteroplasia: diagnosis, treatment, and prognosis. Appl Clin Genet. 2015; 8:37-48. PMC: 4321643. DOI: 10.2147/TACG.S51064. View